FLORDIS has released details of a clinical observational study of its Femular unique black cohosh extract, which has for the first time proven a dose dependent effect in relieving menopausal symtoms.
The study, published recently in the Phytomedicine journal, also demonstrated efficacy and tolerability for up to nine months.
Dr Lily Tomas, president of the Australasian Integrative Medicine Association said it is critical that clinically relevant and statistically significant trials are performed on interventions such as black cohosh.
She said the Femular study provides healthcare professionals the "much needed confidence to continue what has already been observed in clinical practice: the value of black cohosh in the relief of menopausal symptoms."
Source Pharmacy Daily Monday September 16th
